Amylyx Pharmaceuticals, Inc. logo AMLX - Amylyx Pharmaceuticals, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 10
HOLD 1
SELL 0
STRONG
SELL 0
| PRICE TARGET: $31.50 DETAILS
HIGH: $40.00
LOW: $24.00
MEDIAN: $31.00
CONSENSUS: $31.50
DOWNSIDE: 10.28%

Profitability Ratios

Ratio Value
GP Margin 0.0%
EBIT Margin 0.0%
EBITDA Margin 0.0%
Operating Margin 0.0%
Pretax Margin 0.0%
Cont. Ops Margin 0.0%
Net Margin 0.0%
Bottom Line Margin 0.0%

Liquidity Ratios

Ratio Value
Current Ratio 14.27
Quick Ratio 14.27
Solvency Ratio -5.266
Cash Ratio 9.99

Valuation Ratios

Ratio Value
Price/Earnings
-7.90
Hist. avg: 20.2
Peer avg not available.
PEG Ratio 0.12
Forward PEG 0.12
Price/Book 3.74
Price/Sales 0.00
Price/FCF -9.25
Price/Op Cash Flow -9.26

Debt Ratios

Ratio Value
Debt/Assets 0.0179
Debt/Equity 0.0195
Debt/Capital 0.0191
Long-Term Debt/Capital 0.0152
Financial Leverage 1.09

Cash Flow Ratios

Ratio Value
Working Capital Turnover 0.00
Operating Cash Flow Ratio -5.436
Operating Cash Flow/Sales 0.0%
Free Cash Flow/Operating Cash Flow 100.1%

Coverage Ratios

Ratio Value
Debt Service Coverage 0.00
Interest Coverage 0.0000
Short-Term Operating Cash Flow Coverage 0.00
Operating Cash Flow Coverage -20.71
Capital Expenditure Coverage -893.79
Dividend + Capital Expenditure Coverage -893.79

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 0.00
EPS -1.531
Debt/Share 0.0630
Cash/Share 3.35
Book Value/Share 3.23
Tangible BV/Share 3.23
Equity/Share 3.23
Operating Cash Flow/Share -1.304
Capital Expenditure/Share 0.001
FCF/Share -1.306

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 1.000
Earnings Before Tax/EBIT 0.944
Price/Fair Value 3.74
Debt/Market Cap 0.0041
Effective Tax Rate -0.0%
Enterprise Value Multiple -6.39